Research

The Face (and Arm) of Treatment for Seizures in VGKC/LGI1 Antibody-Associated Limbic Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120382/

Learn more
Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men February 27, 2021

http://n.neurology.org/content/82/7/550.long

Learn more
Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis February 27, 2021

http://www.epilepsybehavior.com/article/S1525-5050(14)00271-6/fulltext

Learn more
Autoimmune encephalitis update February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022229/

Learn more
Treating seizures and preventing amnesia in LGI1-antibody encephalitis February 27, 2021

http://nn.neurology.org/content/2/6/e182

Learn more
Cognitive behavioral therapy after acquired brain injury: maintenance of therapeutic benefits at 6 months post-treatment February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/22411108

Learn more
Hyponatremia and voltage gated potassium channel antibody associated limbic encephalitis February 27, 2021

https://www.omicsonline.org/open-access/hyponatremia-and-voltage-gated-potassium-channel-antibody-associated-limbic-encephalitis-2155-9562-5-195.php?aid=24048

Learn more
Paraneoplastic syndromes and autoimmune encephalitis, Five new things February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613202/

Learn more
“Light switch” mental status changes and irritable insomnia are two particularly salient features of anti-NMDA receptor antibody encephalitis. February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/24938143

Learn more
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563251/

Learn more